Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma.

Wu, Jiebin; Sun, Min; Li, Zhizhen; Shen, Yang; Wu, Yingjun; Zhang, Hesong; Xu, Zhichao; Gao, Qingxiang

Wu, Jiebin; Sun, Min; Li, Zhizhen; Shen, Yang; Wu, Yingjun; Zhang, Hesong; Xu, Zhichao; Gao, Qingxiang.

Afiliación

Wu J; Department of Hepatobiliary Surgery, The Second People's Hospital of Wuhu, Wuhu, China.
Sun M; Department of Hepatobiliary Surgery, The Second People's Hospital of Wuhu, Wuhu, China.
Li Z; Department of Biliary Tract Surgery, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Shen Y; Department of Biliary Tract Surgery, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Wu Y; Department of Biliary Tract Surgery, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Zhang H; Department of Hepatobiliary Surgery, The Second People's Hospital of Wuhu, Wuhu, China.
Xu Z; Department of Hepatobiliary Surgery, The Second People's Hospital of Wuhu, Wuhu, China.
Gao Q; Department of Biliary Tract Surgery, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.

J Gastrointest Oncol ; 14(3): 1434-1450, 2023 Jun 30.

Article en En | MEDLINE | ID: mdl-37435232

Palabras clave

Plasminogen activator urokinase (PLAU); immune infiltration; liver hepatocellular carcinoma (LIHC); prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Gastrointest Oncol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google